United States · Bill · HR
H.R. 2629 (107th)
Hematological Cancer Research Investment and Education Act of 2001
Introduced
25 July 2001
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2025
Summary
Hematological Cancer Research Investment and Education Act of 2001 - Amends the Public Health Service Act to require the Director of: (1) the National Institutes of Health to expand, intensify, and coordinate programs for the conduct and support of research with respect to blood cancer, particularly with respect to leukemia, lymphoma, and multiple myeloma; (2) the Centers for Disease Control and Prevention to establish a related public information program, to be carried out in collaboration with private health organizations that have national education and patient assistance programs on blood-related cancers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 27 July 2001
Introduced in House (PDF)
Introduced in House · EN · 27 July 2001
Introduced in House
summary · EN · 25 July 2001
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/2629
- Open data entity: https://api.congress.gov/v3/bill/107/hr/2629